For Medication Information Inquiries

SUBMIT AN INQUIRY ONLINE >
 

Phone Icon1-833-GBIOSCI

Phone Icon(833)424-6724

EPIDIOLEX® (cannabidiol)

EPIDIOLEX® (cannabidiol) oral solution is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in patients 2 years of age and older.

*Safety Data Sheets disclose important information about safe handling of medicines.
 

 

Recent Publications

EPIDIOLEX® (cannabidiol) oral solution is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in patients 2 years of age and older.
 

Below are links to publications about EPIDIOLEX from the Phase 3 studies that supported approval by the US Food and Drug Administration (FDA).
 

The links to these reprints are being provided for educational purposes only. The data reported in these publications may differ from or may not be included in the full Prescribing Information. See link to full prescribing information above. Prescription drugs used outside of their approved indications may not be eligible for reimbursement by third-party payers including Medicare, Medicaid or similar federal or state programs. Financial and conflict of interest disclosures are included within each respective publication.
 

CANNABINOID EDUCATIONAL RESOURCES

For more information about cannabinoids, access the resources at the links below.

CANNABINOID CLINICAL WEBSITE >

DOWNLOADABLE CANNABINOID GLOSSARY >

Find additional information for healthcare professionals, patients, and caregivers about epilepsy, Dravet syndrome, and Lennox-Gastaut syndrome.

LEARN MORE >

PRODUCT PIPELINE

View the Greenwich Biosciences Pipeline for information about medicines in development.

Learn More >

CLINICAL TRIALS

Access ClinicalTrials.gov for a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. It is a service of the US National Institutes of Health.

SEARCH ClinicalTrials.gov >

Grant Requests

Greenwich Biosciences is proud to support continuing medical education for healthcare professionals, helping to ensure that their patients receive the highest quality of care.

Our primary areas of focus for educational support are cannabinoid science and disorders of the central nervous system, including epilepsy. This global program is open to physicians, researchers, and institutions interested in conducting external research. 
 

Grant requests should include: 

• A letter of request including the amount you are requesting

• A detailed proposal including a draft agenda, needs assessment, the target audience, number of participants anticipated, and accreditation (if applicable)

• Overall budget for the program

• Any additional information to aid in our review

Please send your requests to grants@greenwichbiosciences.com.